AR038594A1 - Composicion administrable por via oral para la fotoproteccion de la piel - Google Patents

Composicion administrable por via oral para la fotoproteccion de la piel

Info

Publication number
AR038594A1
AR038594A1 ARP030100588A ARP030100588A AR038594A1 AR 038594 A1 AR038594 A1 AR 038594A1 AR P030100588 A ARP030100588 A AR P030100588A AR P030100588 A ARP030100588 A AR P030100588A AR 038594 A1 AR038594 A1 AR 038594A1
Authority
AR
Argentina
Prior art keywords
photoprotection
skin
carotenoid
carotene
oral route
Prior art date
Application number
ARP030100588A
Other languages
English (en)
Original Assignee
Nestle Sa
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa, Oreal filed Critical Nestle Sa
Publication of AR038594A1 publication Critical patent/AR038594A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composición administrable por vía oral para la fotoprotección de la piel, la cual comprende una combinación de: i) al menos una bacteria láctica probiótica o un sobrenadante de cultivo de la misma, y ii) al menos un carotenoide o derivado, incluido en un vehículo aceptable por vía oral. Reivindicación 2: Una composición de acuerdo a la reivindicación 1, en donde la bacteria láctica es seleccionada del grupo que consiste en Lactobacilos y/o Bifidobacterias. Reivindicación 6: Una composición de acuerdo con una de las reivindicaciones 1 a 5, en donde el carotenoide es un carotenoide con o sin actividad de la provitamina A, tal como beta-caroteno, yeta-caroteno, alfa-caroteno, licopeno, zeaxantina y lucteina, o una mezcla de los mismos.
ARP030100588A 2002-02-21 2003-02-24 Composicion administrable por via oral para la fotoproteccion de la piel AR038594A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075703 2002-02-21

Publications (1)

Publication Number Publication Date
AR038594A1 true AR038594A1 (es) 2005-01-19

Family

ID=27741186

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100588A AR038594A1 (es) 2002-02-21 2003-02-24 Composicion administrable por via oral para la fotoproteccion de la piel

Country Status (23)

Country Link
US (2) US20050069505A1 (es)
EP (1) EP1478329B1 (es)
JP (1) JP2005526038A (es)
KR (1) KR20040096604A (es)
CN (1) CN1301708C (es)
AR (1) AR038594A1 (es)
AT (1) ATE325604T1 (es)
AU (1) AU2003232184B2 (es)
BR (1) BR0307875B1 (es)
CA (1) CA2477144C (es)
DE (1) DE60305159T2 (es)
DK (1) DK1478329T3 (es)
ES (1) ES2263990T3 (es)
HK (1) HK1079104A1 (es)
MX (1) MXPA04008177A (es)
NO (1) NO20043848L (es)
PL (1) PL372146A1 (es)
PT (1) PT1478329E (es)
RU (1) RU2309760C2 (es)
TW (1) TWI344845B (es)
UA (1) UA77066C2 (es)
WO (1) WO2003070203A1 (es)
ZA (1) ZA200407551B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0307839A (pt) * 2002-02-21 2004-12-07 Nestle Sa Composição fotoprotetora para a pele que pode ser administrada por via oral
KR20040096604A (ko) * 2002-02-21 2004-11-16 소시에떼 데 프로듀이 네슬레 소시에떼아노님 피부의 광보호용 경구 투여성 조성물
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
MXPA06006394A (es) * 2003-12-04 2007-01-25 Biofilms Strategies Inc Metodos y composiciones para prevenir formaciones de biopeliculas, reducir biopeliculas existentes y para reducir poblaciones de bacterias.
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
US20060269508A1 (en) 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
ES2640212T3 (es) 2005-04-08 2017-11-02 The Procter & Gamble Company Uso de bifidobacterias pro bióticas administradas por vía oral para obtener beneficios de belleza en seres humanos
AT501919B1 (de) * 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
US20110082218A1 (en) * 2006-06-15 2011-04-07 Karin Wertz Treatment and modulation of gene expression and skin aging
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
ES2559008T3 (es) * 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
EP2522355B1 (en) * 2010-01-06 2018-02-21 Kabushiki Kaisha Yakult Honsha Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application
EP2586448B1 (en) * 2010-06-28 2018-02-07 Kabushiki Kaisha Yakult Honsha Skin properties improving agent for oral administration
US9259019B2 (en) * 2010-11-11 2016-02-16 Mars, Incorporated Bifidobacteriumstrain
US10226491B2 (en) 2011-04-08 2019-03-12 Chr. Hansen A/S Synergistic antimicrobial effect
US10039296B2 (en) 2011-06-20 2018-08-07 H.J. Heinz Company Brands Llc Probiotic compositions and methods
US9113653B2 (en) * 2011-08-19 2015-08-25 Steven J Maranz Methods of administering probiotic organisms that synthesize carotenoid compounds in situ to enhance human health and nutrition
CN110201003A (zh) 2012-02-29 2019-09-06 伊西康内外科公司 微生物区系的组合物及与其相关的方法
PL2836588T3 (pl) 2012-04-09 2017-08-31 Chr. Hansen A/S Bioprotekcja z zastosowaniem szczepów Lactobacillus paracasei
BR112014024918B1 (pt) 2012-04-09 2022-04-19 Chr. Hansen A/S Composição antifúngica, seus usos, produto lácteo e método de preparação do mesmo
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US20160271189A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
US11235010B2 (en) 2015-10-07 2022-02-01 Galderma Research & Development Composition containing lactic acid bacteria and its use to treat atopic dermatitis
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
ES2966383T3 (es) * 2017-11-28 2024-04-22 Dermapharm Ag Composición para el tratamiento de la disbiosis de la microbiota intestinal
DE102018000033A1 (de) * 2018-01-03 2019-07-25 Torsten Schott Verfahren zur beschleunigten Allgemein- und Hautregeneration sowie Wundheilung
GB202115797D0 (en) * 2021-11-03 2021-12-15 Iiaa Ltd Compositions comprising probiotic and postbiotic strains of bacteria

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US539773A (en) * 1895-05-21 Carburetor
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
US4646362A (en) * 1985-01-10 1987-03-03 Kimberly-Clark Corporation Disposable underpants, such as child's training pants and the like
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US5223491A (en) 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
CH680972A5 (es) * 1990-09-28 1992-12-31 Nestle Sa
EP0577904B1 (fr) * 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
FR2698268B1 (fr) 1992-11-24 1995-01-20 Oreal Composition photoprotectrice administrée par voie orale.
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
FR2718752B1 (fr) 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FR2725896B1 (fr) 1994-10-19 1996-11-29 Sederma Sa Nouvelles compositions cosmetiques ou dermopharmaceutiques
IT1274654B (it) 1995-02-28 1997-07-18 Newpharma Srl Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US6030650A (en) * 1996-11-22 2000-02-29 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
ATE214597T1 (de) * 1997-12-19 2002-04-15 Merck Patent Gmbh Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
ATE314858T1 (de) * 1998-04-01 2006-02-15 Ganeden Biotech Inc Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen
DE19819475A1 (de) * 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
JP2001000142A (ja) * 1999-06-23 2001-01-09 Artnature Co Ltd 育毛および発毛用栄養補助食品
IL148142A (en) * 1999-09-09 2005-06-19 Nestle Sa Method for improving condition of elderly pets and pet food therefor
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
BR0109496A (pt) * 2000-03-24 2002-12-10 Nestle Sa Uso de bactéria do ácido láctico para o tratamento de peritonite
EP1151673A3 (en) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
EP1593382A1 (en) * 2000-10-06 2005-11-09 Société des Produits Nestlé S.A. Use of probiotic lactic bacteria for balancing the skin's immune system
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
RU2334404C2 (ru) * 2002-02-21 2008-09-27 Сосьете Де Продюи Нестле С.А. Композиция корма для домашних животных для защиты их кожи от действия света
BR0307839A (pt) * 2002-02-21 2004-12-07 Nestle Sa Composição fotoprotetora para a pele que pode ser administrada por via oral
KR20040096604A (ko) * 2002-02-21 2004-11-16 소시에떼 데 프로듀이 네슬레 소시에떼아노님 피부의 광보호용 경구 투여성 조성물

Also Published As

Publication number Publication date
MXPA04008177A (es) 2005-06-08
CN1635865A (zh) 2005-07-06
BR0307875B1 (pt) 2014-12-23
PT1478329E (pt) 2006-09-29
AU2003232184B2 (en) 2008-11-13
EP1478329A1 (en) 2004-11-24
DE60305159T2 (de) 2007-03-15
CA2477144C (en) 2011-06-14
UA77066C2 (en) 2006-10-16
EP1478329B1 (en) 2006-05-10
RU2309760C2 (ru) 2007-11-10
PL372146A1 (en) 2005-07-11
CA2477144A1 (en) 2003-08-28
DK1478329T3 (da) 2006-08-28
WO2003070203A1 (en) 2003-08-28
US10688139B2 (en) 2020-06-23
JP2005526038A (ja) 2005-09-02
TW200307555A (en) 2003-12-16
US20050069505A1 (en) 2005-03-31
US20070280999A1 (en) 2007-12-06
BR0307875A (pt) 2004-12-28
ZA200407551B (en) 2005-10-12
NO20043848L (no) 2004-09-14
AU2003232184A1 (en) 2003-09-09
RU2004127986A (ru) 2005-05-10
ATE325604T1 (de) 2006-06-15
TWI344845B (en) 2011-07-11
DE60305159D1 (de) 2006-06-14
HK1079104A1 (en) 2006-03-31
CN1301708C (zh) 2007-02-28
KR20040096604A (ko) 2004-11-16
ES2263990T3 (es) 2006-12-16

Similar Documents

Publication Publication Date Title
AR038594A1 (es) Composicion administrable por via oral para la fotoproteccion de la piel
AR038592A1 (es) Composicion fotoprotectora de la piel administrable por via oral
PE20061107A1 (es) Composiciones de tigeciclina y metodos para su preparacion
AR113011A1 (es) Vesículas extracelulares bacterianas
AR071493A1 (es) Traustoquitridos, composiciones de acidos grasos, y metodos de elaboracion y usos de los mismos
WO2006104610A3 (en) Trans carotenoids, their synthesis, formulation and uses
AR060387A1 (es) Suplementos alimenticios y sus usos
BRPI0712269A2 (pt) Método para isolamento de um microorganismo tolerante ao butanol, microorganismo, método para o isolamento, lactobacillus tolerantes ao butanol, métodos para a produção de butanol, lactobacillus tolerante à 2-butanona e métodos para a produção de 2-butanona
ES2076784T3 (es) Barra solida para el aseo.
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
AR086272A2 (es) Anticuerpos anti-factor d humanizados y sus usos
AR048405A1 (es) Composiciones que contienen isomeros cis de un compuesto carotenoide
ES2170771T3 (es) Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos.
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
RU2008147883A (ru) Применение молочнокислых бактерий для уменьшения детской колики
CO6150136A2 (es) Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne
DOP2002000545A (es) Moléculas pequeñas para el tratamiento del crecimiento celular anormal
HN2002000341A (es) Composiciones farmaceuticas para el tratamiento de la diabetis mellitus
PL307245A1 (en) Catalysts and their application in oxidation of saturated hydrocarbons
ES2073475T3 (es) Secuencias de dna utilizables en la sintesis de carotenoides.
BR0209093A (pt) Processo para produzir uma xantofila mono- ou poli-oxidada
WO2014041528A2 (en) A composition
AR065034A1 (es) Metodos para prevenir y tratar trastornos neurodegenerativos
RS20070095A (en) Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
AR071762A1 (es) Derivados 5-hidroximetil-oxazolidin-2-ona para el tratamiento de enfermedades intestinales bacteriales

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee